Search Results
Institute of Pathology, University Hospital Halle (Saale), Halle (Saale), Germany
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Paul Stewardson in
Google Scholar
PubMed
Search for other papers by John B McIntyre in
Google Scholar
PubMed
Search for other papers by Adrian Box in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Search for other papers by Martin Hyrcza in
Google Scholar
PubMed
Search for other papers by Konstantin Koro in
Google Scholar
PubMed
Search for other papers by Dean Ruether in
Google Scholar
PubMed
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
= 87), ATA intermediate ( n = 126), and ATA low ( n = 256) recurrence risk and non-invasive follicular thyroid neoplasm with papillary-like nuclear features or MTC patients ( n = 13) (230 new patients/year). All new patients with thyroid cancer in
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Joachim N Nilsson in
Google Scholar
PubMed
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jonathan Siikanen in
Google Scholar
PubMed
Search for other papers by Vincenzo Condello in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Kenbugul Jatta in
Google Scholar
PubMed
Search for other papers by Ravi Saini in
Google Scholar
PubMed
Stockholms Sjukhem Foundation's Research and Development Department, Stockholm, Sweden
Department of Clinical Sciences Lund, Lund University, Lund, Sweden
Search for other papers by Christel Hedman in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Catharina Ihre Lundgren in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
size, histological type (follicular or papillary) and high [ 18 F]fluorodeoxyglucose uptake ( 2 , 3 , 4 , 5 ). Furthermore, tumours exhibiting BRAF V600E or TERT promoter mutations are less likely to spawn iodine avid metastases and are